Project Number 3R24OD028257-03S1 Agency/Funding Organization OD Funding Year 2022 View Full Project Details for Targeted Immunotherapy in a Nonhuman Primate Model of Alzheimers Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator ENGELMAN, KATHLEEN Principal Investigator First Name KATHLEEN Principal Investigator Last Name ENGELMAN Awardee Organization UNIV OF MASSACHUSETTS MED SCH WORCESTER Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) FY Overall Cost $267,811 Funding Organization Agency/Funding Organization OD Funding Organization Country United States Program Official ARNEGARD, MATTHEW ERIN
